Raclopride lessens the ability of clozapine to suppress alcohol drinking in Syrian golden hamsters

Neuropharmacology

Volumn 61, Issue 4, 2011, Pages 646-652

  Chau, David T ^a   Ahmed, Jayme ^a   Wang, Thomas T ^a   Xie, Haiyi ^a   Dawson, Ree ^b   Green, Alan I ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

Author keywords

Alcoholism; Clozapine; D2 receptor; Dopamine; Raclopride; Schizophrenia

Indexed keywords

CLOZAPINE; RACLOPRIDE;

ADJUVANT THERAPY; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER;

ALCOHOL DRINKING; ANIMALS; CLOZAPINE; CRICETINAE; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; MALE; MESOCRICETUS; RACLOPRIDE; RECEPTORS, DOPAMINE D2;

EID: 79960006713     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.05.007     Document Type: Article

References (44)

1. M.J. Albanese, E.J. Khantzian, S.L. Murphy, and A.I. Green Decreased substance use in chronically psychotic patients treated with clozapine Am. J. Psychiatry 151 1994 780 781 (Pubitemid 24140576)
2. C.R. Ashby Jr., and R.Y. Wang Pharmacological actions of the atypical antipsychotic drug clozapine: a review Synapse 24 1996 349 394 (Pubitemid 26418687)
3. E.S. Brown, V.A. Nejtek, D.C. Perantie, N. Rajan Thomas, and A.J. Rush Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation J. Clin. Psychopharmacol. 23 2003 384 388 (Pubitemid 36951181)
4. M.F. Brunette, R. Dawson, C. O'Keefe, P. Buckley, and A.I. Green An open label study of quetiapine in patients with schizophrenia and alcohol disorders Mental Health and Substance Use 2 2009 203 211
5. D.T. Chau, R.M. Roth, and A.I. Green The neural circuitry of reward and its relevance to psychiatric disorders Curr. Psychiatry Rep. 6 2004 391 399 (Pubitemid 39591820)
6. D.T. Chau, D. Gulick, H. Xie, R. Dawson, and A.I. Green Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters Neuropharmacology 58 2010 351 356
7. J.T. Coyle Substance use disorders and schizophrenia: a question of shared glutamatergic mechanisms Neurotox. Res. 10 2006 221 233
8. A.Y. Deutch, B. Moghaddam, R.B. Innis, J.H. Krystal, G.K. Aghajanian, B.S. Bunney, and D.S. Charney Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia Schizophr. Res. 4 1991 121 156
9. R.E. Drake, F.C. Osher, and M.A. Wallach Alcohol use and abuse in schizophrenia. A prospective community study J. Nerv. Ment. Dis. 177 1989 408 414 (Pubitemid 19185431)
10. R.E. Drake, H. Xie, G.J. McHugo, and A.I. Green The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia Schizophr. Bull. 26 2000 441 449 (Pubitemid 30423220)
11. A.I. Green, S.V. Zimmet, R.D. Strous, and J.J. Schildkraut Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv. Rev. Psychiatry 6 1999 287 296 (Pubitemid 29132022)
12. A.I. Green, E.S. Burgess, R. Dawson, S.V. Zimmet, and R.D. Strous Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone Schizophr. Res. 60 2003 81 85 (Pubitemid 36015790)
13. A.I. Green, D.T. Chau, W.M. Keung, R. Dawson, R.I. Mesholam, and J.J. Schildkraut Clozapine reduces alcohol drinking in Syrian golden hamsters Psychiatry Res. 128 2004 9 20 (Pubitemid 39265478)
14. A.I. Green, D.L. Noordsy, M.F. Brunette, and C. O'Keefe Substance abuse and schizophrenia: pharmacotherapeutic intervention J. Subst. Abuse Treat. 34 2008 61 71 (Pubitemid 350216350)
15. K. Ingman, and E.R. Korpi Alcohol drinking of alcohol-preferring AA rats is differentially affected by clozapine and olanzapine Eur. J. Pharmacol. 534 2006 133 140 (Pubitemid 43384194)
16. R.I. Jennrich, and M.D. Schluchter Unbalanced repeated-measures models with structured covariance matrices Biometrics 42 1986 805 820 (Pubitemid 17134900)
17. H.L. June, K.R. Domangue, R.W. Hughes, H.L. Spurlock, and M.J. Lewis Differential effects of dopamine and serotonin antagonists on ethanol self-administration Alcohol. Clin. Exp. Res. 15 1991 316
18. H.O. Kalkman, and E. Loetscher alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs Eur. J. Pharmacol. 462 2003 33 40 (Pubitemid 36183732)
19. S. Kapur, and G. Remington Serotonin-dopamine interaction and its relevance to schizophrenia Am. J. Psychiatry 153 1996 466 476 (Pubitemid 26113309)
20. S. Kapur, R.A. McClelland, S.C. VanderSpek, M.L. Wadenberg, G. Baker, J. Nobrega, R.B. Zipursky, and P. Seeman Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action Neuroreport 13 2002 831 835 (Pubitemid 34492910)
21. S. Kapur, S.C. VanderSpek, B.A. Brownlee, and J.N. Nobrega Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy J. Pharmacol. Exp. Ther. 305 2003 625 631 (Pubitemid 36459179)
22. W.M. Keung, L. Kunze, D.J. Li, and O. Lazo Volitional ethanol consumption affects overall serotonin metabolism in Syrian golden hamsters (Mesocricetus auratus) Biochem. Biophys. Res. Commun. 271 2000 823 830 (Pubitemid 30444712)
23. P.J. Kulkosky, and N.W. Cornell Free-choice ethanol intake and ethanol metabolism in the hamster and rat Pharmacol. Biochem. Behav. 11 1979 439 444 (Pubitemid 10180164)
24. N.M. Laird, and J.H. Ware Random-effects models for longitudinal data Biometrics 38 1982 963 974
25. M.L. Lee, R.A. Dickson, M. Campbell, J. Oliphant, H. Gretton, and J.T. Dalby Clozapine and substance abuse in patients with schizophrenia Can. J. Psychiatry 43 1998 855 856 (Pubitemid 28518678)
26. A.D. Levy, J.M. Murphy, W.J. McBride, L. Lumeng, and T.K. Li Microinjection of sulpiride into the nucleus accumbens increases ethanol drinking in alcohol-preferring (P) rats Alcohol Alcohol. Suppl. 1 1991 417 420
27. P. Marcus, and R. Snyder Reduction of comorbid substance abuse with clozapine Am. J. Psychiatry 152 1995 959
28. M.M. Marcus, K.E. Jardemark, M.L. Wadenberg, X. Langlois, P. Hertel, and T.H. Svensson Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat Int. J. Neuropsychopharmacol. 8 2005 315 327 (Pubitemid 41002487)
29. D.E. McMillan, F.W. Ellis, G.D. Frye, and J.R. Pick Failure of signs of physical dependence to develop in hamsters after prolonged consumption of large doses of ethanol Pharmacol. Biochem. Behav. 7 1977 55 57 (Pubitemid 8186070)
30. R.I. Melendez, Z.A. Rodd, W.J. McBride, and J.M. Murphy Dopamine receptor regulation of ethanol intake and extracellular dopamine levels in the ventral pallidum of alcohol preferring (P) rats Drug Alcohol Depend. 77 2005 293 301 (Pubitemid 40283531)
31. S. Potvin, E. Stip, O. Lipp, R. Elie, A. Mancini-Marie, M.F. Demers, M.A. Roy, R.H. Bouchard, and A. Gendron Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial Curr. Med. Res. Opin. 22 2006 1277 1285 (Pubitemid 44085579)
32. D.A. Regier, M.E. Farmer, D.S. Rae, B.Z. Locke, S.J. Keith, L.L. Judd, and F.K. Goodwin Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study J. Am. Med. Assoc. 264 1990 2511 2518
33. SAS Institute, Inc. SAS/STAT User's Guide, Version 9.2 2008 SAS Institute, Inc. Cary, NC
34. J.S. Silvestre, M.F. O'Neill, A.G. Fernandez, and J.M. Palacios Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat Eur. J. Pharmacol. 318 1996 257 265 (Pubitemid 27046266)
35. T.H. Svensson Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 1145 1158 (Pubitemid 37464959)
36. T.H. Svensson Preclinical effects of conventional and atypical antipsychotic drugs: defining the mechanisms of action Clin. Neurosci. Res. 3 2003 34 46 (Pubitemid 36975295)
37. T.H. Svensson, J.M. Mathe, J.L. Andersson, G.G. Nomikos, B.E. Hildebrand, and M. Marcus Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected] J. Clin. Psychopharmacol. 15 1995 11S 18S
38. F.I. Tarazi, O. Shirakawa, and C.A. Tamminga Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects Eur. J. Pharmacol. 232 1993 71 77 (Pubitemid 23056999)
39. M.J. Thrasher, P.A. Freeman, and F.O. Risinger Clozapine's effects on ethanol's motivational properties Alcohol. Clin. Exp. Res. 23 1999 1377 1385 (Pubitemid 29409352)
40. M. Ufer, M. Dadmarz, and W.H. Vogel Voluntary consumption of amphetamine, cocaine, ethanol and morphine by rats as influenced by a preceding period of forced drug intake and clozapine Pharmacology 58 1999 285 291 (Pubitemid 29206183)
41. M.L. Wadenberg, S. Kapur, A. Soliman, C. Jones, and F. Vaccarino Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats Psychopharmacology (Berl) 150 2000 422 429 (Pubitemid 30470221)
42. H. Walter, K. Ramskogler, B. Semler, O.M. Lesch, and W. Platz Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials J. Biomed. Sci. 8 2001 83 88 (Pubitemid 32098489)
43. Y. Yovell, and L.A. Opler Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis J. Nerv. Ment. Dis. 182 1994 591 592 (Pubitemid 24318417)
44. S.V. Zimmet, R.D. Strous, E.S. Burgess, S. Kohnstamm, and A.I. Green Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey J. Clin. Psychopharmacol. 20 2000 94 98 (Pubitemid 30056360)